APA (7th ed.) Citation

Abdelqader, S., Abuhijli, F., Abuhijlih, R., Al-Masri, H., Kana'an, H., Alnsour, A., . . . Abdel-Razeq, H. (2023). PO-1298 Clinical predictors of dosimetric precedence for (DIBH) radiation therapy for breast cancer. Radiotherapy & Oncology, 182, S1040. https://doi.org/10.1016/S0167-8140(23)09295-2

Chicago Style (17th ed.) Citation

Abdelqader, S., F. Abuhijli, R. Abuhijlih, H. Al-Masri, H. Kana'an, A. Alnsour, S. Mheid, I. Mohamad, and H. Abdel-Razeq. "PO-1298 Clinical Predictors of Dosimetric Precedence for (DIBH) Radiation Therapy for Breast Cancer." Radiotherapy & Oncology 182 (2023): S1040. https://doi.org/10.1016/S0167-8140(23)09295-2.

MLA (9th ed.) Citation

Abdelqader, S., et al. "PO-1298 Clinical Predictors of Dosimetric Precedence for (DIBH) Radiation Therapy for Breast Cancer." Radiotherapy & Oncology, vol. 182, 2023, p. S1040, https://doi.org/10.1016/S0167-8140(23)09295-2.